Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.13 (
protein kinase C
)
49,245
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
SSeCKS and its human orthologue, Gravin, are large scaffolding proteins that are thought to facilitate mitogenic control by anchoring key signal mediators such as protein kinase (PK) C, PKA, the plasma membrane associated isoform of
alpha-1,4-galactosyltransferase
(GalTase), beta2-adrenergic receptor, and cyclins. SSeCKS is also a major
PKC
substrate and phosphatidylserine-dependent
PKC
binding protein whose phosphorylation sites shares homology with a site in the MARCKS protein that encodes phosphorylation-sensitive calmodulin (CaM) binding activity. In the present study, we mapped the in vitro binding sites for CaM and cyclins on SSeCKS. Four CaM binding sites were identified by binding assays that conform to the so-called 1-5-10 motif. Notably, CaM binding was antagonized by prephosphorylation of SSeCKS by
PKC
. We also identified two major cyclin binding (CY) sites that overlap a major
PKC
phosphorylation site in SSeCKS (Ser(507/515)), and showed that cyclin D binding is attenuated if SSeCKS is prephosphorylated by
PKC
. These data suggest that the scaffolding activities of SSeCKS are modulated by mitogenically stimulated kinases such as
PKC
.
...
PMID:Calmodulin and cyclin D anchoring sites on the Src-suppressed C kinase substrate, SSeCKS. 1182 Jul 72